Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30068863HIVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS30068864HIVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS30068865HIVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS20000889HPVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS20024504HPVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS20066292HPVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS20020491HPVENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TVIS44022865HTLV-1ENSG00000104365.16protein_codingIKBKBNoNo3551O14920
TCGA Plot Options
Drug Information
GeneIKBKB
DrugBank IDDB00244
Drug NameMesalazine
Target IDBE0001154
UniProt IDO14920
Regulation Typeinhibitor
PubMed IDs11151876; 12950415; 11054378
CitationsBantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K: Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol. 2000 Dec;95(12):3452-7.@@Allgayer H: Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther. 2003 Sep;18 Suppl 2:10-4.@@Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000 Nov;119(5):1209-18.
GroupsApproved
Direct ClassificationAminobenzoic acids
SMILESNC1=CC(C(O)=O)=C(O)C=C1
Pathways
PharmGKBPA450384
ChEMBLCHEMBL704